Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

NeuroPace Stock News

NPCENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$12.46

-0.20-1.58%

At close: -

$12.46

0.000.00%

After Hours: 4:00 PM EDT

NeuroPace (NPCE) Forecast

News

Earnings NeuroPace (NPCE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest NeuroPace Stock News | NASDAQ:NPCE | Benzinga

Get the latest news on NeuroPace stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on NeuroPace performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, May 28, 2025

Analyst Expectations For NeuroPace's Future
Benzinga Insights
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
HC Wainwright & Co. Initiates Coverage On Neu...
Benzinga Newsdesk

Tuesday, May 27, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?
Vandana Singh
Dow Surges Over 600 Points; US Durable Goods Orders Fall in April
Avi Kapoor
Neuropace shares are trading lower after the ...
Benzinga Newsdesk
Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings
Avi Kapoor
Neuropace Reaffirms Its Previously Issued Ful...
Benzinga Newsdesk
NeuroPace Announces Preliminary Primary Endpo...
Benzinga Newsdesk

Wednesday, May 14, 2025

JP Morgan Maintains Overweight on NeuroPace, ...
Benzinga Newsdesk
Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Neuropace shares are trading higher after the...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ne...
Benzinga Newsdesk

Tuesday, May 13, 2025

NeuroPace Raises FY2025 Sales Guidance from $...
Benzinga Newsdesk
NeuroPace Q1 EPS $(0.21) Beats $(0.24) Estima...
Benzinga Newsdesk
Earnings Scheduled For May 13, 2025
Benzinga Insights

Monday, April 14, 2025

Neuropace Provides An Update On Its Exposure ...
Benzinga Newsdesk

Wednesday, April 09, 2025

Kura Sushi Posts Downbeat Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor

Tuesday, April 08, 2025

NeuroPace Presented Data From Long-Term Post-...
Benzinga Newsdesk

Wednesday, April 02, 2025

NeuroPace Maintains 2025 Revenue Guidance And...
Benzinga Newsdesk
NeuroPace Terminates Distribution Relationshi...
Benzinga Newsdesk

Wednesday, March 05, 2025

What 4 Analyst Ratings Have To Say About NeuroPace
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Neu...
Benzinga Newsdesk

Tuesday, March 04, 2025

NeuroPace Affirms FY2025 Sales Guidance of $9...
Benzinga Newsdesk
NeuroPace Q4 EPS $(0.18) Beats $(0.22) Estima...
Benzinga Newsdesk
Earnings Scheduled For March 4, 2025
Benzinga Insights

Friday, February 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Neuropace shares are trading lower after the ...
Benzinga Newsdesk
NeuroPace Prices Public Offering Of 6.50M Sha...
Benzinga Newsdesk

Thursday, February 13, 2025

Neuropace Announces That It Intends To Offer ...
Benzinga Newsdesk

Monday, February 03, 2025

NeuroPace To Present Data From Post-Approval ...
Benzinga Newsdesk

Thursday, January 30, 2025

Wells Fargo Maintains Overweight on NeuroPace...
Benzinga Newsdesk

Tuesday, January 28, 2025

NeuroPace Expects FY25 Revenue Of $92M – $96M...
Benzinga Newsdesk

Tuesday, January 21, 2025

Neurospace shares are trading higher after UB...
Benzinga Newsdesk
UBS Initiates Coverage On NeuroPace with Buy ...
Benzinga Newsdesk

Wednesday, January 08, 2025

NeuroPace Sees Prelim. Q4 Revenue $21M-$21.5M...
Benzinga Newsdesk

Tuesday, January 07, 2025

Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor

Thursday, December 26, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Tuesday, December 17, 2024

JP Morgan Maintains Overweight on NeuroPace, ...
Benzinga Newsdesk

Tuesday, December 03, 2024

NeuroPace Completes Enrollment In Feasibility...
Benzinga Newsdesk

Wednesday, November 13, 2024

Neuropace shares are trading higher after the...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on NeuroPace...
Benzinga Newsdesk

Tuesday, November 12, 2024

NeuroPace Q3 2024 GAAP EPS $(0.19) Beats $(0....
Benzinga Newsdesk
NeuroPace Raises FY2024 Sales Guidance from $...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights

Monday, November 04, 2024

NueroPace Announced FDA Submission Of Its Thr...
Benzinga Newsdesk

Wednesday, August 14, 2024

Neuropace shares are trading lower. The compa...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved